Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Theratechnologies Inc
T.TH
Alternate Symbol(s):
THTX
Healthcare
Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs...
in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:TH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 6:20pm
RE:RE:RE:RE:10years ago
But they have a plan... raise money, regroup the stock and kiss Investissement Qcs a.. as.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 6:14pm
RE:RE:RE:10years ago
It's going to help do acquisitions and all for sure. Running around the FDA for paperwork, managing Marathon and the Nasdaq... F..k
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 6:09pm
RE:RE:10years ago
This risk was on the table always. We could'nt afford it with the dept level thx to all that Th1902 nothing.
(30)
•••
muslix1
X
View Profile
View Bullboard History
Comment by
muslix1
on Sep 17, 2024 6:04pm
RE:10years ago
Levesque be a man take a pay cut for that mistake... poor CEO
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Post by
palinc2000
on Sep 17, 2024 5:57pm
10years ago
https://stockhouse.com/news/press-releases/2014/05/23/additional-update-on-availability-of-egrifta-r-tesamorelin-for-injection-in-the
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 5:45pm
RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
That's the nail in the box. We coul'nt afford this at this time.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 5:40pm
RE:RE:RE:RE:RE:New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
Oh I forget we will have a nasdaq problem again soon I suppose.
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 5:37pm
RE:RE:RE:RE:New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
So we are facing uncertainty about their ability to exist for the next 6 months I guess. What will Marathon say about this. Will they loose Egrifta patients if there is a shortage.
...more
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 17, 2024 5:26pm
RE:RE:RE:New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
That's for Trogarzo I think... sick of this
(200)
•••
palinc2000
X
View Profile
View Bullboard History
Comment by
palinc2000
on Sep 17, 2024 5:11pm
RE:RE:New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
They were supposed to have an alternative supply option
(2)
•••
ANALIAS00
X
View Profile
View Bullboard History
Comment by
ANALIAS00
on Sep 17, 2024 5:05pm
RE:New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
Am I surprise that another brick hit the wall !?!?!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Sep 17, 2024 5:00pm
New Press Release - Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
MONTREAL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced a risk of a temporary supply disruption for...
read article.
(30)
•••
muslix1
X
View Profile
View Bullboard History
Comment by
muslix1
on Sep 16, 2024 11:01pm
RE:RE:Pfizer
Trogarzo, ask yourself why they left Pfizer or why Pfizer thanked them....Lol
(107)
•••
Trogarzon
X
View Profile
View Bullboard History
Comment by
Trogarzon
on Sep 16, 2024 3:45pm
RE:Pfizer
Pfizer is gathering interest from its Cachexia drug. Anyone here Egrifta trial from Cachexia.. they have sortilin targeted radioactive stuff too.. and everyone there comes from Pfizer.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden